The Asia Pacific market for structural heart closure devices will grow robustly, fueled by strong expansion of the PFO and LAA closure device spaces.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the structural heart closure device market in Asia Pacific across a 10-year period.


The Asia Pacific market for structural heart closure devices will grow robustly through 2026.

Which segment contributed the most to Asia Pacific revenues in 2017?

What are the different growth trends by region? How has the reimbursement landscape changed for structural heart closure procedures in the various country?

Which companies are the market leaders in the Asia Pacific structural heart closure device market? What strategies will domestic companies use to compete in the Chinese market?

The LAA closure device segment represents a significant market opportunity for manufacturers in the structural heart closure device space.

How will Lifetech Scientific compete with Abbott Laboratories? What strategies these companies will adopt to sustain in this dynamic and competitive market?

Which competitor is the market leader in Asia Pacific LAA closure device market, and why?

How do Asia Pacific countries differ in terms of the adoption of epicardial and endocardial LAA closure devices, and how will these differences affect trends going forward?

The Asia Pacific market for PFO closure devices has faced challenges in the past but is positioned for growth given recent positive clinical data.

What new clinical evidence challenges the historically troubled body of evidence for PFO closure? 

How will the penetration of PFO closure devices differ within the Asia Pacific countries?

Table of contents

  • Asia Pacific
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Structural Heart Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • First-Mover Advantage
        • Domestic Competitors
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Product Portfolio Management
        • Regulatory Environment
        • Mergers, Acquisitions, and Partnerships
        • Pricing Strategies and Purchasing Options
        • Distribution and Sales Network
        • Local Marketing Strategies
      • Market Developments
    • Congenital Heart Defect Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Atrial Septal Defect Closure Device Market
        • Patent Ductus Arteriosus Closure Device Market
        • Ventricular Septal Defect Closure Device Market
        • Australia
        • China
        • India
        • South Korea
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Product Portfolio Management
    • Patent Foramen Ovale Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Left Atrial Appendage Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Endocardial Left Atrial Appendage Closure Devices
        • Epicardial Left Atrial Appendage Closure Devices
        • Australia
        • China
        • India
        • South Korea
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • First-Mover Advantage
        • Domestic Competitors
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Product Portfolio Management
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Ashish Bhupal, MBA

Ashish Bhupal is a team lead within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in clot managment, vascular access, aortic repair, heart valve, structural heart, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Managment from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution. Follow Ashish on Twitter: @Ashishb_DRG.


Related Reports

Structural Heart Closure Devices | Medtech 360 | Market Insights | Global

The global market for structural heart closure devices will grow rapidly in most countries covered through 2028, driven by strong clinical data, the availability of reimbursement, a...

View Details

Structural Heart Closure Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for structural heart closure devices will grow robustly, fueled by strong expansion of the 

View Details